Literature DB >> 12581948

Absence of an impact of emotional distress on the perception of intracardiac shock discharges.

Karl-Heinz Ladwig1, Birgitt Marten-Mittag, Günter Lehmann, Harald Gündel, Heidi Simon, Eckhard Alt.   

Abstract

The pain of transvenous cardioversion shocks in awake patients is an important clinical problem. It is unknown whether psychological factors modulate any observed variation in pain perception. Thirty-seven patients with chronic atrial fibrillation (AF; mean age 61.9 years, 29 men, 8 women) were consecutively included in the study. Pain perception of a low energy test shock (60V, 0.1J) during internal cardioversion was assessed immediately following the stimulus. Before treatment anxiety, depression, somatization were evaluated. The intracardiac shock was perceived as hypalgesic in 15 (41%) patients, as normalgesic in 10 (27%), and as hyperalgesic in 10 (32%) patients. Pain threshold was significantly lower in patients in which AF was accidentally diagnosed (p < 0.029). Age, sex, and the level of education were equally distributed over the three pain groups. The hyperalgesic pain threshold was not associated with anxiety, depression, or the patients' tendency to amplify benign bodily sensations. This study discloses a wide range of perceived pain intensity caused by a homogenous intracardiac stimulation. Anxiety and depression do not amplify perception of intracardiac shocks. Sensory gating mechanisms may play a more important role in the level of intracardiac shock perception than distressing affective factors.

Entities:  

Mesh:

Year:  2003        PMID: 12581948     DOI: 10.1207/s15327558ijbm1001_05

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  23 in total

1.  A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion.

Authors:  E Alt; R Ammer; C Schmitt; F Evans; G Lehmann; J Pasquantonio; A Schömig
Journal:  Eur Heart J       Date:  1997-11       Impact factor: 29.983

2.  Internal cardioversion of chronic atrial fibrillation in patients.

Authors:  R Neri; P Palermo; A S Cesario; D Baragli; E Amici; G Gambelli
Journal:  Pacing Clin Electrophysiol       Date:  1997-09       Impact factor: 1.976

3.  Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation.

Authors:  G Boriani; M Biffi; G Bronzetti; G M Ayers; R Zannoli; A Branzi; A Capucci; B Magnani
Journal:  Am J Cardiol       Date:  1998-01-15       Impact factor: 2.778

4.  Testing different biphasic waveforms and capacitances: effect on atrial defibrillation threshold and pain perception.

Authors:  G Tomassoni; K H Newby; M M Kearney; M J Brandon; H Barold; A Natale
Journal:  J Am Coll Cardiol       Date:  1996-09       Impact factor: 24.094

5.  Prepulses reduce the pain of cutaneous electrical shocks.

Authors:  T D Blumenthal; T T Burnett; C D Swerdlow
Journal:  Psychosom Med       Date:  2001 Mar-Apr       Impact factor: 4.312

6.  Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system.

Authors:  N S Lok; C P Lau; H F Tse; G M Ayers
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

7.  [Psychologic screening of patients of a cardiologic acute care clinic with the German version of the Hospital Anxiety and Depression Scale].

Authors:  C Herrmann; K H Scholz; H Kreuzer
Journal:  Psychother Psychosom Med Psychol       Date:  1991-02

8.  Enzymatically and electrocardiographically estimated infarct size in relation to pain in acute myocardial infarction.

Authors:  J Herlitz; A Hjalmarson; S Holmberg; K Swedberg; F Waagstein; A Waldenström; J Waldenström
Journal:  Cardiology       Date:  1984       Impact factor: 1.869

9.  Anxiety and depression in patients with chest pain referred for exercise testing.

Authors:  K S Channer; M Papouchado; M A James; J R Rees
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

10.  Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias.

Authors:  A W Nathan; R S Bexton; R A Spurrell; A J Camm
Journal:  Br Heart J       Date:  1984-10
View more
  6 in total

1.  Low-energy multistage atrial defibrillation therapy terminates atrial fibrillation with less energy than a single shock.

Authors:  Wenwen Li; Ajit H Janardhan; Vadim V Fedorov; Qun Sha; Richard B Schuessler; Igor R Efimov
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-10-06

2.  Multistage electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation with lower energy than a single biphasic shock.

Authors:  Ajit H Janardhan; Sarah R Gutbrod; Wenwen Li; Di Lang; Richard B Schuessler; Igor R Efimov
Journal:  J Am Coll Cardiol       Date:  2013-09-26       Impact factor: 24.094

3.  Termination of sustained atrial flutter and fibrillation using low-voltage multiple-shock therapy.

Authors:  Christina M Ambrosi; Crystal M Ripplinger; Igor R Efimov; Vadim V Fedorov
Journal:  Heart Rhythm       Date:  2010-10-19       Impact factor: 6.343

4.  [Psychological comorbidity and quality of life in patients with an implantable cardioverter/defribrillator (ICD)].

Authors:  K-H Ladwig; J Ronel; J Baumert; C Kolb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

Review 5.  Electrical Stimulation for Low-Energy Termination of Cardiac Arrhythmias: a Review.

Authors:  Skylar Buchan; Ronit Kar; Mathews John; Allison Post; Mehdi Razavi
Journal:  Cardiovasc Drugs Ther       Date:  2021-08-07       Impact factor: 3.727

6.  Novel Low-Voltage MultiPulse Therapy to Terminate Atrial Fibrillation.

Authors:  Fu Siong Ng; Ondřej Toman; Jan Petru; Petr Peichl; Roger A Winkle; Vivek Y Reddy; Petr Neuzil; R Hardwin Mead; Norman A Qureshi; Zachary I Whinnett; David W Bourn; M Brent Shelton; Josef Kautzner; Arjun D Sharma; Meleze Hocini; Michel Haïssaguerre; Nicholas S Peters; Igor R Efimov
Journal:  JACC Clin Electrophysiol       Date:  2021-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.